EP0331185A2 - Photographisches Silberhalogenidelement für die Erzeugung direktpositiver Bilder und Verfahren zur Herstellung solcher Bilder - Google Patents

Photographisches Silberhalogenidelement für die Erzeugung direktpositiver Bilder und Verfahren zur Herstellung solcher Bilder Download PDF

Info

Publication number
EP0331185A2
EP0331185A2 EP89103759A EP89103759A EP0331185A2 EP 0331185 A2 EP0331185 A2 EP 0331185A2 EP 89103759 A EP89103759 A EP 89103759A EP 89103759 A EP89103759 A EP 89103759A EP 0331185 A2 EP0331185 A2 EP 0331185A2
Authority
EP
European Patent Office
Prior art keywords
group
silver halide
photographic
mol
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP89103759A
Other languages
English (en)
French (fr)
Other versions
EP0331185A3 (de
Inventor
Kazunori Hayashi
Nobuaki Inoue
Shingo Nishiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5128888A external-priority patent/JPH01224758A/ja
Priority claimed from JP15988788A external-priority patent/JPH028836A/ja
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Publication of EP0331185A2 publication Critical patent/EP0331185A2/de
Publication of EP0331185A3 publication Critical patent/EP0331185A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/005Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/485Direct positive emulsions
    • G03C1/48538Direct positive emulsions non-prefogged, i.e. fogged after imagewise exposure

Definitions

  • This invention relates to a silver halide photographic element capable of quickly forming direct positive images when using a processing solution having a high stability, and to an image forming process using the photographic element. More specifically, the invention relates to a silver halide photographic element for computer output (light-sensitive film for COM) and also to an image forming process using the photographic element.
  • the finishing speed of the film is slow since the processing step is complicated and also the maximum density (Dmax) and the minimum density (Dmin) are liable to deviate. Furthermore, in the aforesaid process, it is necessary to use a strong oxidizing agent such as potassium bichromate, etc., for bleaching, which causes a problem of environmental pollution.
  • a strong oxidizing agent such as potassium bichromate, etc.
  • a process of forming positive images using a direct positive silver halide photographic element can be mainly classified into the following two types from the viewpoint of practical usefulness.
  • previously fogged silver halide emulsions are used and after development, direct positive images are obtained by destroying fogged nuclei (latent images) at exposed portions by utilizing a solarization or Herschel effect.
  • unfogged internal latent image type silver halide emulsions are used and direct positive images are obtained by applying a surface development after or while applying fogging treatment after image exposure.
  • the aforesaid internal latent image type silver halide photographic emulsion is a silver halide photographic emulsion of a type having the sensitive specks mainly in the inside of the silver halide grain and forming latent images mainly in the inside of the silver halide grain by light exposure.
  • the process of the latter type has generally a high sensitivity as compared with the process of the former type and is suitable for the uses of requiring high sensitivity.
  • the present invention relates to the latter type process.
  • fogged nuclei are selectively formed at the surfaces only of silver halide grains in the unexposed portions by the so-called surface desensitizing action based on the internal latent images formed in the inside of the silver halide grains by an initial imagewise exposure and then a so-called ordinary surface development is applied to form photographic images (direct positive images) at the unexposed portions.
  • a so-called "light fogging method” of applying a second light exposure on the entire surface of the light-sensitive element e.g., British Patent 1,151,363
  • a so-called “chemical fogging method” using a nucleating agent are known.
  • the latter method is described, e.g., in Research Disclosure, Vol. 151, No. 15162, pages 72-87, (November, 1976).
  • the conventional chemical fogging method has the following disadvantages. That is, the nucleating agent used shows acts as a nucleating agent at a high pH of at least 12. At such a high pH condition, the developing agent is liable to deteriorate by air oxidation, which results in greatly reducing the development activity. Also, a long time is required for processing due to the slow development rate and if a developer of low pH is used, the processing time is further prolonged. Furthermore, even when pH of the developer is higher than 12, it takes a long time for finishing the development.
  • the light fogging method does not require a high pH condition and is relatively advantageous for practical use.
  • the light fogging method is based on the formation of fogged nuclei by the photodecomposition of silver halide, the proper exposure illuminance and the proper exposure amount in the method differ according to the kind and the characteristics of the silver halide being used. Thus, it is difficult to obtain a constant performance with this method.
  • the development apparatus is complicated and expensive. Still further, there is a disadvantage of requiring a long time for the development.
  • JP-A-52-69613 the term "JP-A” as used herein means an "unexamined published Japanese patent application”
  • U.S. Patents 3,615,615 and 3,850,638 the term "JP-A” as used herein means an "unexamined published Japanese patent application”
  • these nucleating agents have a disadvantage in that the nucleating agents act with silver halide or decompose during the storage of the photographic light-sensitive elements containing them before processing, which results in reducing the maximum image density after processing.
  • U.S. Patent 3,227,552 describes that the development rate for an intermediate density is increased by using a hydroquinone derivative.
  • the development rate is not sufficiently high and in particular, when the pH of the developer is below 12, the development rate is insufficient.
  • JP-A-60-170843 describes that the maximum image density is increased by adding a mercapto compound having a carboxylic acid group or a sulfonic acid group. However, the effect obtained by the addition of the compound is less.
  • JP-A-55-134848 describes that the minimum image density is reduced by processing using a processing solution (pH 12.0) containing a tetraazaindene series compound in the presence of a nucleating agent to prevent the formation of re-reversed negative images.
  • a processing solution pH 12.0
  • the maximum image density is not increased and also the development rate is not increased.
  • JP-B-45-12709 (the term "JP-B” as used herein means an "examined published Japanese patent application”) describes that a triazoline-thione series compound or a tetrazoline-thione series compound is added to a light-sensitive element for forming direct positive images by a light fogging method.
  • JP-B the term "JP-B” as used herein means an "examined published Japanese patent application”
  • Japanese Patent Application No. 61-136949 and JP-A-63-8740 describe techniques of solving the aforesaid problems but these methods are not sufficient from the point of the prevention of the re-reversed negative images.
  • a 1 st object of this invention is to provide a process of quickly and stably forming direct positive images having a high Dmax and low Dmin by processing a previously unfogged internal latent image type silver halide photographic element in the presence of a nucleating agent.
  • a 2nd object of this invention is to provide a direct positive silver halide photographic element for a COM film utilizing an internal latent image type silver halide emulsion and reversibility due to a nucleating agent.
  • a 3rd object of this invention is to provide a direct positive silver halide photographic element having a low occurrence of re-reversed negative images in a high illuminance exposure.
  • a 4th object of this invention is to provide a process of forming direct positive images with a low deviation of Dmax and Dmin even when the pH of a developer is changed.
  • a 5th object of this invention is to provide a direct positive silver halide photographic element having a low deviation of Dmax and Dmin even when the photographic element is stored for a long period of time.
  • the invention is a process of forming a direct positive images comprising; (A) imagewise exposing a silver halide photographic element comprising a support having thereon at least one photographic emulsion layer containing previously unfogged internal latent image type silver halide grains, and, (B) developing the resulting photographic element, wherein said photographic emulsion layer or another hydrophilic colloid layer contains a nucleating agent and said photographic emulsion layer contains a sensitizing dye represented by formula (I) and wherein development is performed in the presence of a nucleating accelerator; wherein Z; and Z 2 , which may be the same or diffrent, each represents an atomic group forming a 5- or 6- membered nitrogen-containing heterocyclic nucleus; I 1 represents 0 or 1; R, and R 2 , which may be the same or different, each represents a substituted or unsubstituted alkyl group having from 1 to 10 carbon atoms or a substituted or unsubstituted alkenyl group having
  • nucleating agent means a compound which acts on a previously unfogged internal latent image type silver halide emulsion, in the case of surface development of the emulsion, to form direct positive images.
  • nucleating agent which can be used in this invention, all of the compounds which have hitherto been developed for nucleating internal latent image type silver halides can be used.
  • the nucleating agents can be used singly or as a mixture thereof.
  • the nucleating agent are described, e.g., in Research Disclosure, No. 22534, pages 50-54 (January, 1983) and these compounds are generally classified into hydrazine series compounds, quaternary heterocyclic compounds, and other compounds.
  • hydrazine series nucleating agents are described, e.g., in Research Disclosure, No. 15162, pages 76-77 (November, 1976) and ibid., No. 23510, pages 346-352 (November, 1983) and practical examples are as follows.
  • hydrazine series nucleating agent having an adsorptive group to silver halide examples are described in U.S. Patents, 4,030,925, 4,080,207, 4,031,127, 3,718,470, 4,269,929, 4,276,364, 4,278,748, 4,385,108, and 4,459,347, British Patent 2,011,391 B, and JP-A-54-74729, JP-A-55-163533, JP-A-55-74536, and JP-A-60-179734.
  • hydrazine series nucleating agents are described, e.g., in JP-A-57-86829 and U.S. Patents 4,560,638, 2,563,785, and 2,588,982.
  • the useful nucleating agents for use in this invention are preferably the compounds shown by following formulae (N-I) and (N-II); wherein Z" represents a non-metallic atomic group necessary for forming a 5- or 6-membered heterocyclic ring, to which an aromatic ring or a heterocyclic ring may be further condensed, R 11 represents an aliphatic group, X represents Q represents a non-metallic atomic group necessary for forming a 4- to 12-membered non-aromatic hydrocarbon ring or a non-aromatic heterocyclic ring, at least one of the substituent for R 11 , the substituent for Z", and the substituent for Q, however, contains an alkinyl group and further at least one of R 11 , Z 11 , and Q may have an adsorption accelerating group to silver halide, Y represents a pair ion for balancing electrostatic charges, and n represents a number necessary for balancing electrostatic charges
  • heterocyclic ring completed by the non-metallic atomic group shown by Z" examples include quinolinium, benzimidazolium, pyridinium, thiazolium, selenazolium, imidazolium, tetrazolium, indolenium, pyrrolidium, phenanthridinium, isoquinolium, and naphthopyridinium.
  • the heterocyclic ring formed by Z 11 may be substituted and examples of the substituents are an alkyl group, an alkenyl group, an aralkyl group, an aryl group, an alkinyl group, a hydroxy group, an alkoxy group, an aryloxy group, a halogen atom, an amino group, an alkylthio group, an arylthio group, an acyloxy group, an acylamino group, a sulfonyl group, a sulfonyloxy group, a sulfonylamino group, a carboxy group, an acyl group, a carbamoyl group, a sulfamoyl group, a sulfo group, a cyano group, a ureido group, a urethane group, a carbonic acid ester group, a hydrazine group, a hydrazone group, and an imino group.
  • Z" may have a heterocyclic quaternary ammonium group which is completed through a proper linkage group L' (wherein L' is a divalent linkage group) as a substituent.
  • L' is a divalent linkage group
  • the compound takes a so-called dimer structure.
  • the heterocyclic skeleton completed by Z 11 is preferably quinolinium, benzimidazolium, pyridinium, acrydinium, phenanthridinium, naphthopyridinium, or isoquinolinium, more preferably quinolinium, naphthopyridinium, or benzimidazolium, and most preferably quinolinium.
  • the aliphatic group shown by R" is preferably an unsubstituted alkyl group having from 1 to 18 carbon atoms or a substituted alkyl group the alkyl moiety of which has from 1 to 18 carbon atoms.
  • substituent for the substituted alkyl group there are the substituents described above for Z".
  • R" preferably an alkinyl group and particularly preferably a propargyl group.
  • Q is an atomic group necessary for forming a 4-to 12-membered non-aromatic hydrocarbon ring or a non-aromatic heterocyclic ring and these rings may be substituted by the substituents described above for Z".
  • non-aromatic hydrocarbon ring which is the case when X is a carbon atom, are cyclopentane, cyclohexane, cyclohexene, cycloheptane, indane, and tetralin.
  • the non-aromatic heterocyclic ring has nitrogen, oxygen, sulfur, selenium, etc., as the hetero atom.
  • X is a carbon atom
  • examples of the non-aromatic heterocyclic ring are tetrahydrofuran, tetrahydropyran, butyrolactone, pyrrolidone, and tetrahydrothiophene.
  • examples thereof are pyrrolidine, piperidine, pyridone, piperazine, perhydrothiazine, tetrahydroquinoline, and indoline.
  • Preferred examples of the rings formed by Q are those wherein X is a carbon atom, such as cyclopentane, cyclohexane, cycloheptane, cyclohexene, indane, tetrahydropyran, and tetrahydrothiophene.
  • R 11 is an alkinyl group.
  • the alkinyl group was already partially described above but is further explained in detail.
  • the alkinyl group has preferably from 2 to 18 carbon atoms and specific examples thereof are ethynyl, propargyl, 2-butynyl, 1-methylpropargyl, 1,1-dimethylpropargyl, 3-butynyl, and 4-pentinyl. Furthermore, these groups may be further substituted by the substituents described as above for Z".
  • the alkinyl is preferably propargyl and the case that R 11 is propargyl is most preferred.
  • the substituents for R", Q, and Z 11 may have an adsorption accelerating group to silver halide and a preferred adsorption accelerating group is shown by X 11 ( ⁇ L 1 ) ⁇ m (wherein X" is an adsorption accelerating group to silver halide, L 1 is a divalent linkage group, and m is 0 or 1).
  • Preferred examples of the adsorption accelerating group to silver halide shown by X 11 are a thioamido group, a mercapto group, and a 5- or 6- membered nitrogen-containing heterocyclic group. These groups may be substituted by the substituents described above as the substituents for Z 11 .
  • a thioamido group an acyclic thioamido group (e.g., thiourethane and thioureido) is preferred.
  • a heterocyclic mercapto group e.g., 5-mercaptotetrazole, 3-mercapto-1,2,4-triazole, 2-mercapto-1,3,4-thiadiazole, and 2-mercapto-1,3,4-oxadiazole is preferred.
  • the 5- or 6-membered nitrogen-containing heterocyclic ring shown by X 11 is composed of a combination of nitrogen, oxygen, sulfur, and carbon and the heterocyclic ring forming imino silver is preferred. Examples thereof are benzotriazole and aminothiazole.
  • ion Y for balancing charges, there are, for example, bromide ion, chloride ion, iodide ion, p-toluenesulfonate ion, ethylsulfonate ion, perchlorate ion, trifluoromethanesulfonate ion, thiocyanate ion, BF 4 -, and PF 6 -.
  • the compound shown by formula (N-I) described above preferably has an adsorption accelerator to silver halide and, particularly preferably has a thioamide group, an azole group, or a heterocyclic mercapto group as the adsorption accelerating group X 11 .
  • R 21 represents an aliphatic group, an aromatic group, or a heterocyclic group
  • R 22 represents a hydrogen atom, an alkyl group, an aralkyl group, an aryl group, an alkoxy group, an aryloxy group, or an amino arou p
  • G represents a carbonyl qroup, a sulfonyl group, a sulfoxy qroup, a phosphoryl qroup, or an iminomethylene group
  • R 23 and R 24 both represent a hydrogen atom or one of them represents a hydrogen atom and the other represents an alkylsulfonyl group, an arylsulfonyl group, or an acyl group
  • G, R 23 and R 24 may form
  • the aliphatic group shown by R 21 in formula (N-II) is a straight chain, branched, or cyclic alkyl group, alkenyl group, or alkinyl group.
  • the aromatic group shown by R 21 is a monocyclic or dicyclic aryl group such as, for example, a phenyl group and a naphthyl group.
  • the heterocyclic group shown by R 21 is a 3- to 10-membered saturated or unsaturated heterocyclic ring containing at least one of nitrogen, oxygen, and sulfur and the ring may be a monocyclic ring or may form a condensed ring with an aromatic ring or a heterocyclic ring.
  • the heterocyclic ring is preferably a 5- or 6- membered aromatic heterocyclic group such as, e.g., a pyridyl group, a quinolinyl group, an imidazolyl group. and a benzimidazolyl group.
  • R 2 may be substituted by a substituent such as an alkyl group, an aralkyl group, an alkoxy group, an alkyl- or aryl-substituted amino group, an acylamino group, a sulfonylamino group, a ureido group, a urethane group, an aryloxy group, a sulfamoyl group, a carbamoyl group, an aryl group, an alkylthio group, an arylthio group, a sulfonyl group, a sulfinyl group, a hydroxy group, a halogen atom, a cyano group, a suifo group and a carboxyl group. These groups may be further substituted.
  • a substituent such as an alkyl group, an aralkyl group, an alkoxy group, an alkyl- or aryl-substituted amino group, an acyla
  • these groups may, if possible, combine with each other to form a ring.
  • R 21 is preferably an aromatic group, an aromatic heterocyclic ring or an aryl-substituted methyl group, and more preferably an aryl group.
  • R 22 is preferably as follows. That is, when G is a carbonyl group, R 22 is preferably a hydrogen atom, an alkyl group (e.g., methyl, trifluoromethyl, 3-hydroxypropyl, and 3-methanesulfonamidopropyl" an aralkyl group (e.g., o-hydroxybenzyl), or an aryl group (e.g., phenyl, 3,5-dichlorophenyl, o-methanesulfonamidophenyl, and 4-methanesulfonylphenyl), and is particularly preferably a hydrogen atom.
  • R 22 is preferably a hydrogen atom, an alkyl group (e.g., methyl, trifluoromethyl, 3-hydroxypropyl, and 3-methanesulfonamidopropyl" an aralkyl group (e.g., o-hydroxybenzyl), or an aryl group (e.g.,
  • R 22 is preferably an alkyl group (e.g., methyl), an aralkyl group (e.g., o-hydroxyphenyl methyl), an aryl group (e.g., a phenyl group), or a substituted amino group (e.g., dimethylamino).
  • substituents for the group shown by R 22 there are the substituents as the substituents for R 21 described above and other substituents such as an acyl group, an acyloxy group, an alkyloxycarbonyl, an aryloxycarbonyl, an alkenyl, an alkinyl, and a nitro group.
  • These groups may be further substituted by the same group(s). Also, if possible, these groups may combine with each other to form a ring.
  • R 21 or R 22 contains a so-called ballast group.
  • the ballast group has at least 8 carbon atoms and is composed of at least one of an alkyl group, a phenyl group, an ether group, an amido group, a ureido group, a urethane group, a sulfonamido group, and a thioether group.
  • R 21 or R 22 may have a group shown by ( ⁇ X 21 L 2 ) ⁇ m2 [wherein X 21 has the same significance as X 11 of formula (N-I) and is preferably a thioamido group (except thiosemicarbazide and the substituents thereof), a mercapto group or a 5- or 6-membered nitrogen-containing heterocyclic group, L 2 represents a divalent linkage group having the same significance as L 1 of formula (N-I), and m 2 represents 0 or 1 ], which accelerates the adsorption of the compound of formula (IV-II) to the surface of silver halide grains.
  • X 21 has the same significance as X 11 of formula (N-I) and is preferably a thioamido group (except thiosemicarbazide and the substituents thereof), a mercapto group or a 5- or 6-membered nitrogen-containing heterocyclic group
  • L 2 represents a divalent linkage group having the same significance
  • X 21 is a cyclic thioamido group (e.g., a mercapto-substituted nitrogen-containing heterocyclic ring such as 2-mercaptothiadiazole, 3-mercaptol,2,4-triazole, 5-mercaptotetrazole, 2-mercapto-1,3,4-oxadiazole, 2-mercaptobenzoxazole, etc.) or a nitrogen-containing heterocyclic group (e.g., benzotriazole, benzimidazole, and indazole).
  • a cyclic thioamido group e.g., a mercapto-substituted nitrogen-containing heterocyclic ring such as 2-mercaptothiadiazole, 3-mercaptol,2,4-triazole, 5-mercaptotetrazole, 2-mercapto-1,3,4-oxadiazole, 2-mercaptobenzoxazole, etc.
  • a nitrogen-containing heterocyclic group e.
  • R 23 and R 24 are most preferably a hydrogen atom, and G is most preferably a carbonyl group.
  • the nucleating agent shown by formula (N-II) has an adsorptive group to silver halide.
  • the particularly preferred absorptive group to silver halide is a mercapto group, a cyclic thioamido group and a nitrogen-containing heterocyclic group as described for formula (N-I).
  • the compound shown by formula (N-I) or (N-II) in this invention may exit in any layer(s) of the photographic light-sensitive material being processed in this invention but preferably exist in the silver halide emulsion layer thereof.
  • the amount of the compound is usually in the range of from about 1x10 -8 mol to about 1x10 -2 mol, and preferably from 1x10 -7 mol to 1x10 -3 mol per mol of silver in the silver halide emulsion layer.
  • nucleating agent is used in combination with the following compounds.
  • JP-A-55-65944 the catechols described in JP-A-55-21013, and JP-A-55-65944, the compound releasing a nucleating agent at development described in JP-A-60-107029, the thioureas described in JP-A-60-95533, and the spirobisindanes described in JP-A-55-65944.
  • nucleating agent shown by formula (N-I) described above is preferred and in this case, it is preferred to employ the following embodiments (1) to (8) in order and embodiment (8) is most preferred.
  • nucleating agent shown by formula (N-I) and the nucleating agent shown by formula (N-II) can be used together.
  • the compound is a cyanine having the longest wavelength adsorption maximum on silver halide of not longer than 590 nm shown by formula (I) wherein Z, and Z 2 , which may be the same or different, each represents an atomic group forming a 5- or 6- membered nitrogen-containing heterocyclic nucleus and I, represents 0 or 1. More preferred heterocyclic nuclei are as follows.
  • Z, and Z 2 which may be the same or different, each represents thiazole, benzothiazole, naphthothiazole, dihydronaphthothiazole, selenazole, benzoselenazole, naphthoselenazole, dihydronaph- thoselenazole, oxazole, benzoxazole, naphthoxazole, benzimidazole, naphthimidazole, pyridine, quinoline, imidazo[4,5-b]quinoquizaline, or 3,3-dialkylindolenine.
  • Z represents thiazoline, thiazole, benzothiazole, selenazoline, selenazole, benzoselenazole, oxazole, benzoxazole, naphthoxazole, imidazole, benzimidazole, naphthimidazole, or pyrroline and Z 2 represents oxazoline, oxazole, benzoxazole, naphthoxazole, thiazoline, selenazoline, pyrroline, benzimidazole, or naphthimidazole.
  • the nitrogen-containing heterocyclic nucleus shown by Z 1 or Z 2 may have one or more substituents.
  • the preferred substituent are a lower alkyl group (which may be branched or may further have a substituent (e.g., a hydroxy group, a halogen atom, an aryl group, an aryloxy group, an arylthio group, a carboxy group, an alkoxy group, an alkylthio group, and an alkoxycarbonyl group) and is more preferably an alkyl group having from 1 to 10 carbon atoms (e.g., methyl, ethyl, butyl, chloroethyl, 2,2,3,3-tetrafluoropropyl, hydroxy, benzyl, tolylethyl, phenoxyethyl, phenylthio ethyl, carboxypropyl, methoxyethyl, ethylthioethyl, and ethoxycarbony
  • nitrogen-containing heterocyclic nucleus shown by Z 1 and Z 2 are thiazoline, 4-methylthiazoline, thiazole, 4-methylthiazole, 4,5-dimethylthiazole, 4-phenylthiazole, benzothiazole, 5-methylbenzothiazole, 6-methylbenzothiazole, 5-ethylbenzothiazole, 5,6-dimethylbenzothiazole, 5-methoxybenzothiazole, 6-methoxybenzothiazole, 5-butoxybenzothiazole, 5,6-dimethoxybenzothiazole, 5-methoxy-6-methylbenzothiazole, 5-chlorobenzothiazole, 5-chloro-6-methylbenzothiazole, 5-phenylbenzothiazole, 5-ac- etylaminobenzothiazole, 6-propionylaminobenzothiazole, 5-hydroxybenzothiazole, 5-hydroxy-6-methylbenzothiazole, 5-ethoxycarbonylbenzothiazole, 5-phen
  • R 1 and R 2 which may be the same or different, each represents an alkyl group or an alkenyl group each having not more than 10 carbon atoms and may have a substituent.
  • substituents for the alkyl group or the alkenyl group there are, for example, a sulfo group, a carboxy group, a halogen atom, a hydroxy group, an alkoxy group having not more than 6 carbon atoms, an aryl group having not more than 8 carbon atoms, which may be substituted (e.g., phenyl, tolyl, sulfophenyl, and carboxyphenyl), a heterocyclic group (e.g., furyl and thienyl), an aryloxy group having not more than 8 carbon atoms, which may be substituted (e.g., chlorophenoxy, phenoxy, sulfophenoxy, and hydrox- yphenoxy), an acyl group having not more than
  • the alkyl group or the alkenyl group may have one or more substituents.
  • alkyl group or alkenyl group shown by R, and R 2 are methyl, ethyl, propyl, allyl pentyl, hexyl, methoxyethyl, ethoxyethyl, phenethyl, tolylethyl, sulfophenethyl, 2,2,2-trifluoroethyl, 2,2,3,3-tetrafluoropropyl, carbamoylethyl, hydroxyethyl, 2-(2 hydroxyethoxy)ethyl, carboxymethyl, carboxyethyl, ethoxycarbonylmethyl, sulfoethyl, 2-chloro-3-sulfopropyl, 3-sulfopropyl, 2-hydroxy-3-sulfopropyl, 3-sulfobutyl, 4-sulfobutyl, 2-(2,3-dihydroxypropyloxy)ethyl, and 2-[2-(3-di
  • R 3 and R s represent a hydrogen atom. Also, R 3 and R, or R 5 and R 2 may combine with each other to form a 5- or 6-membered ring.
  • R 4 represents a hydrogen atom or a lower alkyl group which may be substituted (e.g., methyl, ethyl, propyl, methoxyethyl, phenethyl, and more preferably an alkyl group having not more than 5 carbon atoms).
  • X 1 represents an acid anion residue and mi represents 0 or 1 and when the dye shown by the formula forms an intramolecular salt, mi is 0.
  • I is 1, Z, is an atomic group necessary for forming a heterocyclic nucleus such as oxazole, benzoxazole, naphthoxazole, etc.
  • Z 2 is an atomic group necessary for forming a heterocyclic nucleus such as benzimidazole or naphthimidazole (the heterocyclic nucleus shown by Z 1 and Z 2 may have at least one substituent as described above but when Z 2 represents a benzimidazole nucleus or a naphthimidazole nucleus, the substituent is preferably an electron attractive substituent), at least one of said R, and R 2 is a group having a sulfo group or a carboxy group, or a hydroxy group, and R 4 is a hydrogen atom.
  • Z is an atomic group forming a benzoxazole nucleus
  • Z 2 is an atomic group forming a benzimidazole nucleus
  • at least one of R, and R 2 is a group having a sulfo group or a carboxy group
  • R 4 is a hydrogen atom
  • l 1 is 1.
  • the heterocyclic nucleus shown by Z 1 and Z 2 may have at least one substituent as described above.
  • the particularly preferred substituent is chlorine, fluorine, a cyano group, an alkoxycarbonyl group having not more than 5 total carbon atoms, an acyl group having not more than 7 total carbon atoms, or a perfluoroalkyl group having not more than 4 carbon atoms, such as trifluoromethyl group, etc.
  • the particularly preferred substituent is a phenyl group having not more than 8 carbon atoms, which may be substituted, an alkyl group having not more than 5 carbon atoms, an alkoxy group having not more than 5 carbon atoms, an acylamino group having not more than 5 total carbon atoms, a carboxy group, an alkoxycarbonyl group having not more than 5 total carbon atoms, a benzyl group, a phenethyl group, or chlorine.
  • the compounds shown by formula (I) described above are known compounds and can be synthesized according to the methods described in JP-A-52-104917, JP-B-48-25652 and JP-B-57-22368, F.M. Hamer, The Chemistry of Heterocyclic Compounds, Vol. 18, A. Weissberger ed., The Cyanine Dyes and Related Compounds, published by Interscience, New York, 1964, D.M. Sturmer, The Chemistry of Heterocyclic Compounds, Vol. 30, page 441, edited by A. Weissberger and E.C. Taylor, published by John Willey and Sons, New York.
  • the compound shown by formula (I) in this invention is incorporated in the internal latent image type silver halide emulsion layer preferably in an amount of from 10- 6 to 10- 2 mol, more preferably from 10- 5 to 10- 3 mol, per mol of silver halide.
  • nucleation accelerator in this invention means a compound which has substantially no function as the nucleating agent described hereinbefore but functions to accelerates the action of a nucleating agent to increase the maximum density of direct positive images and/or to shorten the development time necessary for obtaining a constant direct positive image density.
  • nucleation accelerators which are advantageously used in this invention are shown by following formula (II): wherein A represents a group adsorbing to silver halide.
  • the group adsorbing to silver halide there are a compound having a mercapto group bonding to a heterocyclic ring, a heterocyclic compound capable of forming imino group, and a hydrocarbon compound having a mercapto group.
  • Examples of the mercapto compound bonding to a heterocyclic ring are substituted or unsubstituted mercaptoazoles (e.g., 5 mercaptotetrazoles, 3-mercapto-1,2,4-triazoles, 2-mercaptoimidazoles, 2-mercapto-1,3,4-thiadiazoles, 5-mercapto 1,2,4-thiadiazoles, 2-mercapto-1,3,4-oxadiazoles, 2-mercapto-1,3,4- selenadiazoles, 2-mercaptoxazoles, 2-mercaptothiazoles, 2-mercaptobenzoxazoles, 2-mercaptobenzimidazoles, and 2-mercaptobenzimidazoles) and substituted or unsubstituted mercaptopyrimidines (e.g., 2-mercaptopyrimidines).
  • substituted or unsubstituted mercaptoazoles e.g., 5 mercaptotetrazoles, 3-mercap
  • heterocyclic compound capable of forming imino silver examples include indazoles, benzimidazoles, benztriazoles, benzoxazoles, benzthiazoles, imidazoles, thiazoles, oxazoles, triazoles, tetrazoles, azaindenes, pyrazoles, and indoles each may be substituted.
  • hydrocarbon compounds having a mercapto group there are, for example, alkylmercaptans, arylmercaptans, alkenylmercaptans, and aralkylmercaptans.
  • Y represents a divalent linkage group composed of an atom or an atomic group selected from hydrogen atom, carbon atom, nitrogen atom, oxygen atom, and sulfur atom.
  • Examples of the divalent linkage group are -S-, -0-,
  • Each of these linkage groups may be bonded to A or a heterocyclic ring as described below through a straight chain or branched alkylene group (e.g., methylene, ethylene, propylene, butylene, hexylene, and 1-methylethylene) or a substituted or unsubstituted arylene group (e.g., phenylene and naphthylene).
  • alkylene group e.g., methylene, ethylene, propylene, butylene, hexylene, and 1-methylethylene
  • arylene group e.g., phenylene and naphthylene
  • R 1 , R 2 , R 3 , R 4 , R s , R o , R 7 , R s , Rg and R 10 each represents a hydrogen atom, a substituted or unsubstituted alkyl group (e.g., methyl, ethyl, propyl, and n-butyl), a substituted or unsubstituted aryl group (e.g., phenyl and 2-methylphenyl), a substituted or unsubstituted alkenyl group (e.g., propenyl and 1-methylvinyl), or a substituted or unsubstituted aralkyl group (e.g., benzyl and phenethyl).
  • a substituted or unsubstituted alkyl group e.g., methyl, ethyl, propyl, and n-butyl
  • a substituted or unsubstituted aryl group e.
  • R represents an organic group containing at least one of a thioether group, an amino group (including a form of salt), an ammonium group, an ether group, and a heterocyclic group (including a form of salt).
  • an organic group there are the groups each formed by the combination of the aforesaid group and a group selected from a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted aralkyl group and a substituted or unsubstituted aryl group.
  • organic group are hydrochlorides of dimethylaminoethyl, aminoethyl, diethylaminoethyl, dibutylaminoethyl, or dimethylaminopropyl; as well as dimethylaminoethylthioethyl, 4-dimethylaminophenyl, 4-dimethylaminobenzyl, methylthioethyl, ethylthiopropyl, 4-methiothio-3-cyanophenyl, methylthiomethyl, trimethylammonioethyl, methoxyethyl, methoxyethoxyethoxyethyl, methoxyethylthioethyl, 3.4- dimethoxyphenyl, 3-chloro-4-methoxyphenyl, morpholinoethyl, 1-imidazolylethyl, morpholinoethyl- thioethyl, pyrrolidinoeth
  • heterocyclic ring examples include tetrazoles, triazoles, imidazoles, thiadiazoles, oxadi azoles, selenadiazoles, oxazoles, thiazoles, benzoxazoles, benzthiazoles, benzimidazoles, and pyrimidines.
  • M represents a hydrogen atom, an alkali metal atom (e.g., sodium and potassium), an ammonium group (e.g., trimethylammonium and dimethylbenzylammonium), or a group capable of forming hydrogen atom or an alkali metal atom under an alkaline condition (e.g., acetyl, cyanoethyl, and methanesulfonyl).
  • an alkali metal atom e.g., sodium and potassium
  • an ammonium group e.g., trimethylammonium and dimethylbenzylammonium
  • a group capable of forming hydrogen atom or an alkali metal atom under an alkaline condition e.g., acetyl, cyanoethyl, and methanesulfonyl.
  • Each of the aforesaid heterocyclic rings may be substituted by a nitro group, a halogen atom (e.g., chlorine and bromine), a mercapto group, a cyano group, a substituted or unsubstituted alkyl group (e.g., methyl, ethyl, propyl, t-butyl, and cyanoethyl), a substituted or unsubstituted aryl group (e.g., phenyl, 4- methanesulfonamidophenyl, 4-methylphenyl, 3,4-dichlorophenyl, and naphthyl), a substituted or unsubstituted alkenyl group (e.g., allyl), a substituted or unsubstituted aralkyl group (e.g., benzyl, 4-methylbenzyl, and phenethyl), a substituted or unsubstituted sul
  • the heterocyclic ring is not substituted by the aforesaid carboxylic acid or the salt thereof, sulfonic acid or the salt thereof, or the hydroxy group.
  • the heterocyclic ring shown by Q of formula (III) is preferably tetrazoles, triazoles, imidazoles, thiadiazoles, and oxadiazoles.
  • Yi, R, mi, and ni have the same significance as those in formula (II).
  • Y 1 , R, mi, ni and M have the same significance as those in formula (II)
  • Q represents an atomic group necessary for forming a 5- or 6-membered heterocyclic ring capable of being formed with imino silver, and represents preferably an atomic group necessary for forming a 5- or 6-membered heterocyclic ring composed of atoms selected from carbon, nitrogen, oxygen, sulfur, and selenium.
  • the heterocyclic ring may be condensed to a carbon aromatic ring or a heterocyclic aromatic ring.
  • heterocyclic ring formed by Q examples include indazoles, benzimidazoles, benzotriazoles, benzoxazoles, benzthiazoles, imidazoles, thiazoles, oxazoles, triazoles, tetrazoles, tetraazaindenes, triazaindenes, diazaindenes, pyrazoles, and indoles.
  • M, R, Yi, and n 1 have the same significance as those in formula (III) and X represents an oxygen atom, a sulfur atom, or a selenium atpm, and is preferably a sulfur atom.
  • R represents a hydrogen atom, a halogen atom (e.g., chlorine and bromine), a nitro group, a mercapto group, an unsubstituted amino group, a substituted or unsubstituted alkyl group (e.g., methyl and ethyl), a substituted or unsubstituted alkenyl group (e.g., propenyl and 1-methylvinyl), a substituted or unsubstituted aralkyl group (e.g., benzyl and phenethyl), a substituted or unsubstituted aryl group (e.g., phenyl and 2-methylphenyl), or ( ⁇ Y 1 ) ⁇ n1 R.
  • a halogen atom e.g., chlorine and bromine
  • a nitro group e.g., methyl and ethyl
  • a substituted or unsubstituted alkenyl group e.
  • R" represents a hydrogen atom, an unsubstituted amino group or ( ⁇ Y 1 ) ⁇ n1 R and when R and R represent ( ⁇ Y 1 ) ⁇ n1 R, they may be the same or different. At least one of said R and R , however, represents ( ⁇ Y 1 ) ⁇ n1 R.
  • R"' represents ( ⁇ Y 1 ) ⁇ n1 R and M, R, Yi, and n 1 have the same significance as those in formula (III).
  • R" and R 12 each represents a hydrogen atom, a halogen atom (e.g., chlorine and bromine), a substituted or unsubstituted amino group (e.g., amino and methylamino), a nitro group, a substituted or unsubstituted alkyl group (e.g., methyl and ethyl), a substituted or unsubstituted alkenyl group (e.g., propenyl and 1-methylvinyl), a substituted or unsubstituted aralkyl group (e.g., benzyl and phenethyl), or a substituted or unsubstituted aryl group (e.g., phenyl and 2-methylphenyl
  • Patents 2,585,388 and 2,541,924 Advance in Heterocyclic Chemistry, 9, 165 (1968), Organic Synthesis, iV, 569 (1963), Journal of the American Chemical Society, 45, 2390 (1923), Chemische Berichte, 9, 465 (1876), JP-B-40-28496 and JP-B-43-4135, JP-A-50-89034, U.S.
  • the nucleating accelerator can be incorporated in the photographic light-sensitive material or a processing solution but is preferably incorporated in the internal latent image type silver halide emulsion or other hydrophilic colloid layers (e.g., interlayer and protective layer) of the photographic light-sensitive material. It is particularly preferred that the nucleating accelerator exists in the silver halide emulsion layer or a layer adjacent thereto.
  • the addition amount of the nucleation accelerator is preferably from 10- 6 to 10- 2 mol, and more preferably from 10- 5 to 10- 2 mol per mol of silver halide.
  • the amount thereof is preferably from 10- 8 to 10- 3 mol, and more preferably from 10- 7 to 10-4 mol per liter of the solution.
  • the previously unfogged internal latent image type silver halide emulsion for use in this invention is a silver halide emulsion containing silver halide grains having previously unfogged surfaces and forming latent images mainly in the inside thereof.
  • the maximum density of the silver halide emulsion in the case of coating a definite amount of the emulsion on a transparent support, light-exposing the emulsion layer for a definite time of from 0.01 second to 10 seconds, developing it by developer A shown below (internal type developer) for 6 minutes at 20 C, and measuring the density by an ordinary photographic density measuring method is preferably at least 5 times, and more preferably at least 10 times higher than the maximum density thereof obtained by coating and light-exposing the emulsion by the same manners as above and developing the emulsion layer by developer B shown below (surface developer) for 5 minutes at 18' C.
  • the typical composition of the silver halide for the silver halide emulsion for use in this invention is silver chloride, silver bromide or a mixed silver halide such as silver chlorobromide, silver chloroiodobromide, and silver iodobromide.
  • the silver halide emulsion which is preferably used in this invention is silver chloro(iodo)bromide, silver (iodo)chloride, or silver (iodo)bromide containing from 0 to 3 mol% silver iodide.
  • the mean grain size (shown by the diameter of the grains when the grain is spherical or similar to spherical, and shown, in the case of cubic grains, the long side length as the grain size) of the silver halide grains is preferably from 0.1 ⁇ m to 2 ⁇ m, and particularly preferably from 0.15 u.m to 1 ⁇ m.
  • the thickness of the shell is preferably from 0.01 u.m to 1 um, and more preferably from 0.05 um to 0.5 um.
  • the grain size distribution of the silver halide grains may be narrow or broad but for improving the graininess and sharpness of images formed, a so-called mono-dispersed emulsion wherein at least 90%, in particular at least 95% by grain number or weight of the entire silver halide grains are within ⁇ 40% (more preferably within ⁇ 30%. and most preferably within 20%) of the mean grain size is preferably used in this invention.
  • two or more kinds of mono-dispersed silver halide emulsions each having a different grain size can be used for emulsion layers having substantially the same color sensitivity or plural silver halide grains each having the same mean grain size but having different sensitivity may be used for one emulsion layer or separate layers.
  • a combination of two or more poly-dispersed silver halide emulsions or a combination of a mono-dispersed emulsion and a poly-dispersed emulsion can be used as a mixture for one emulsion layer or for double or multi layers.
  • the silver halide grains for use in this invention may have a regular crystal form such as cubic, octahedral dodecahedral, tetradecahedral, etc., an irregular crystal form such as spherical, etc., or a composite form of these crystal forms.
  • the silver halide grains may be tabular grains and in this case, a tabular grain silver halide emulsion wherein tabular grains having an aspect ratio (length/thickness ⁇ of at least 5, in particular at least 8, account for at least 50% of the total projected area of the silver halide grains can be used in this invention.
  • An emulsion composed of silver halide emulsions having these different crystal forms can be used.
  • the silver halide emulsion for use in this invention can be prepared in the presence of a silver halide solvent.
  • a silver halide solvent there are organic thio ethers described in U.S. Patents 3,271,157, 3,531,289, and 3,574,628, JP-A-54-1019 and JP-A-54-158917 and thiourea derivatives described in JP-A-53-82408, JP-A-55-77737, and JP-A-55-2982.
  • the silver halide emulsion for use in this invention can be chemically sensitized in the inside of the grains or at the surface of the grains by a sulfur sensitization, a selenium sensitization, a reduction sensitization, and a noble metal sensitization solely or as a combination thereof.
  • sensitizing dyes e.g., cyanine dyes and merocyanine dyes
  • JP-A-55-52050 pages 45 to 53 in addition to the sensitizing dyes specified in this invention for increasing the sensitivity.
  • sensitizing dyes may be used singly or as a combination thereof and a combination of sensitizing dyes is frequently used for super color sensitization.
  • the silver halide emulsion may further contain a dye which does not have a spectral sensitization action by itself or a material which does not substantially adsorb visible light but shows a super color sensitization effect together with the sensitizing dyes.
  • sensitizing dyes described above may be added in an amount of from 10- 5 to 10- 3 mol per mol of silver halide.
  • the sensitizing dye, etc. can be added in any step of producing a silver halide photographic emulsion or in any step from the production of the emulsion to coating.
  • the sensitizing dye, etc. may be added to a silver halide emulsion at the formation of silver halide grains, at physical ripening, or at chemical ripening.
  • the silver halide emulsion layer or another hydrophilic colloid layer in this invention may also contain water-soluble dyes as filter dyes, irradiation prevention, or other various purposes.
  • filter dye there are dyes for further reducing the photographic sensitivity and dyes having light absorption in the region of mainly from 350 nm to 600 nm for increasing the safety for safelight.
  • These dyes are incorporated in a silver halide emulsion layer or added together with a mordant to a light-insensitive hydrophilic colloid layer disposed on a silver halide emulsion layer followed by fixing.
  • the amount of the dye differs according to a mol extinction coefficient but is usually from 10- 2 g/m 2 to 1 g/m 2 , and preferably from 50 mg/m 2 to 500 mg/m 2 .
  • the photographic light-sensitive materials for use in this invention can further contain various compounds for preventing the formation of fog during the production, storage and/or photographic processing of the photographic materials or stabilizing the photographic performance thereof. That is, there are many compounds known as antifoggants or stabilizers.
  • azoles such as benzothiazolium salts, nitroindazoles, chlorobenzimidazoles, bromobenzimidazoles, mercaptothiazoles, mercaptobenzothiazoles, mercaptothiadiazoles, aminotriazoles, benzothiazoles, nitrobenztriazoles, etc.; mercaptopyrimidines, mercaptotriazines; thioketo compounds such as oxazolinethione; azaindenes such as triazaindenes, tetraazaindenes (in particular, 4-hydroxy-substituted (1,3,3a,7)tetraazaindenes), pentaazaindenes; benzenethiosulfonic acid, benzenesulfinic acid, benzenesulfonic acid amide, etc.
  • azaindenes such as triazaindenes, tetraazaindenes (in particular, 4-hydroxy-substit
  • the photographic light-sensitive materials for use in this invention may contain in the photographic emulsion layers or another hydrophilic colloid layers a developing agent such as polyalkylene oxide or the derivatives thereof (such as the ethers, esters, amines, etc.), thioether compounds, thiomorpholines, quaternary ammonium salt compounds, urethane derivatives, urea derivatives, imidazole derivatives, dihydroxybenzenes, 3-pyrazolidines, etc., for increasing the sensitivity and contrast and for the purpose of development acceleration.
  • a developing agent such as polyalkylene oxide or the derivatives thereof (such as the ethers, esters, amines, etc.), thioether compounds, thiomorpholines, quaternary ammonium salt compounds, urethane derivatives, urea derivatives, imidazole derivatives, dihydroxybenzenes, 3-pyrazolidines, etc.
  • dihydroxybenzenes hydroquinone, 2-methylhydroquinone, catechol, etc.
  • 3- pyrazolidones (1-phenyl-3-pyrazolidone, 1-phenyl-4-methyl-4-hydroxymethyl-3-pyrazolidone, etc.) and polyalkylene oxide compounds shown below are preferred. They are usually used in an amount of not more than 5 g/m 2.
  • a dihydroxybenzene is more preferably used in an amount of from 0.01 to 1 g/m 2 and a 3-pyrazolidone is used more preferably in an amount of from 0.01 to 0.2 g/m 2 .
  • the polyalkylene oxide compounds are used for greatly improving so-called discrimination by increasing the maximum image density without increasing the minimum image density.
  • the coating amount of silver can be reduced in the case of obtaining a definite density, which increases the development acceleration and reduces the cost for processing.
  • polyalkylene oxide compounds for use in this invention there are those shown by following formulae ((XI-1), (XI-2), and (XI-3); R' 1 -A'( ⁇ CH 2 CH 2 O) ⁇ n,1 H (XI-1) wherein R represents a substituted or unsubstituted alkyl group having from 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group, or a substituted or unsubstituted aryl group; A represents -0-, -S-,-COO-, (wherein R 10 represents a hydrogen atom or a substituted or unsubstituted alkyl group);
  • R and R 8 in formula (XI-3) each represents a substituted or unsubstituted alkyl group, an aryl group, an alkoxy group, a halogen atom, an acyl group, an amido group, a sulfonamido group, a carbamoyl group, or a sulfamoyl group.
  • the substituents for the two phenyl groups may be bilaterally symmetric or asymmetric.
  • R' 4 and R' 5 each represents a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aryl group.
  • said R and R' 5 , said R and R' 7 , and said R and R may combine with each other to form a substituted or unsubstituted ring.
  • n' 1 , n2, n' 3 , and n' 4 each shows the average polymerization degree of ethylene oxide and is a number of from 2 to 50, and m shows an average polymerization degree and is a number of from 2 to 50.
  • R' 1 is preferably an alkyl group having from 4 to 24 carbon atoms, an alkenyl group, or an alkylaryl group, and is particularly preferably hexyl, dodecyl, isostearyl, oleyl, t-butylphenyl, 2,4-di-t-butylphenyl, 2,4-di-t-pentylphenyl, p-dodecylphenyl, m-pentadecaphenyl, t-octylphenyl, 2,4-dinonylphenyl, octylnaphthyl, etc.
  • R' 2 , R 3, R' 6 , R 7 , R and R' 9 each is a substituted or unsubstituted alkyl group having from 1 to 20 carbon atoms, such as methyl, ethyl, i-propyl, t-butyl, t-amyl, t-hexyl, t-octyl, nonyi, decyl, dodecyl, trichloromethyl, tribromomethyl, 1-phenylethyl, 2 phenyl-2-propyl, etc., a substituted or unsubstituted aryl group such as phenyl, p-chlorophenyl, etc., a substituted or unsubstituted alkoxy group shown by -OR' 11 (wherein R' 11 represents a substituted or unsubstituted alkyl group having from 1 to 20 carbon atoms or an aryl group
  • R' 6 and R' 8 are preferably an alkyl group or a halogen atom, and particularly preferably a tertiary alkyl group such as bulky t-butyl, t-amyl, t-octyl, etc. Also, R and R are particularly preferably a hydrogen atom. That is, the compound of formula (XI-3) synthesized from a 2,4-di-substituted phenol is particularly preferred.
  • R' 4 and R' 5 are preferably a hydrogen atom, a substituted or unsubstituted alkyl group (e.g., methyl, ethyl, n-propyl, i-propyl, n heptyl, I-ethylamyl, n-undecyl, trichloromethyl, and tribromomethyl), or a substituted or unsubstituted aryl group (e.g., a-furyl, phenyl, naphthyl, p-chlorophenyl, p-methoxyphenyl, and m-nitrophenyl).
  • a substituted or unsubstituted alkyl group e.g., methyl, ethyl, n-propyl, i-propyl, n heptyl, I-ethylamyl, n-undecyl, trichloromethyl, and tribromomethyl
  • R ' 4 and R' 5 , said R 6 and R' 7 , and said R and R 9 may combine with each other to form a substituted or unsubstituted ring such as, e.g, a cyclohexyl ring.
  • R and R are particularly preferably a hydrogen atom, an alkyl group having from 1 to 8 carbon atoms, a phenyl group, or a furyl group.
  • n' 1 , n' 2 , n' 3 , and n' are particularly preferably a number of from 5 to 30 and n' 3 and n' 4 may be the same or different.
  • the amount of the polyalkylene oxide compound shown by formula (XI-1), (XI-2) or (XI-3) for use in this invention is from 5 to 500 mg, and particularly preferably from 10 to 300 mg per square meter of the photographic light-sensitive element.
  • the photographic light-sensitive elements for use in this invention may contain an inorganic or organic hardening agent in the silver halide photographic emulsion layers and another hydrophilic colloid layers.
  • the hardening agent are active vinyl compounds (e.g., 1,3,5-triacryloyl-hexahydro-s-triazine, bis(vinylsulfonyl)methyl, ether, and N,N' -methylenebis-[.B-(vinylsulfonyl)propionamide], active halogen compounds (e.g., 2,4-dichloro-6-hydroxy-s-triazine), mucohalogenic acids (e.g., mucochloric acid), N-carbamoylpyridinium salts (e.g., (1-morpholinocarbonyl-3-pyridinio)methanesulfonate , and haloamidinium salts (e.g., 1-(1-chloro-1-pyridinomethylene
  • the photographic light-sensitive element for use in this invention may further contain various kinds of surface active agents in the photographic emulsion layers or another hydrophilic colloid layers for the purposes of coating aid, static prevention, slidability improvement, sticking prevention, and the improvement of photographic characteristics (e.g., development acceleration, contrast increase and sensitization).
  • nonionic surface active agents such as saponin (steroid series), alkylene oxide derivatives (e.g., polyethylene glycol, a polyethylene glycol/polypropylene glycol condensation product, polyethylene glycol alkyl ethers, polyethylene glycol alkylaryl ethers, polyethylene glycol esters, polyethylene glycol sorbitan esters, polyalkylene glycol alkylamines, polyalkylene glycol alkylamides, and polyethylene oxide addition products of silicone), glycidol derivatives (e.g., alkenylsuccinic acid polyglyceride and alkylphenol polyglyceride), fatty acid esters of polyhydric alcohol, alkyl esters of saccharides, etc.; anionic surface active agents having an acid group (e.g., a carboxy group, a sulfo group, a phospho group, a sulfuric acid ester group, and a phosphoric acid ester), such as alkylcar
  • the nitrogen-containing surface active agents described in JP-A-60-80849, etc. can be preferably used.
  • the photographic light-sensitive elements for use in this invention can further contain the photographic emulsion layers and/or another hydrophilic colloid layers a matting agent such as silica, magnesium oxide, barium strontium sulfate, polymethyl methacrylate particles, etc., for the purpose of sticking prevention.
  • a matting agent such as silica, magnesium oxide, barium strontium sulfate, polymethyl methacrylate particles, etc.
  • the photographic light-sensitive elements for use in this invention may contain a dispersion of a water-insoluble or water sparingly soluble synthetic polymer for improving the properties of the photographic layers.
  • a water-insoluble or water sparingly soluble synthetic polymer for improving the properties of the photographic layers.
  • the polymer are the polymers or copolymers of alkyl (meth)acrylate, alkox- yacryl (meth)acrylate, glycidyl (meth)acrylate, etc., solely or as a combination thereof, or as a combination of the aforesaid monomer and acrylic acid, methacrylic acid, etc.
  • gelatin is advantageously used but another hydrophilic colloid can be used.
  • hydrophilic colloid are proteins such as gelatin derivatives, graft polymers of gelatin and other polymers, albumin, casein, etc.; cellulose derivatives such as hydroxyethyl cellulose, carboxymethyl cellulose, cellulose sulfuric acid esters, etc.; saccharide derivatives such as sodium alginate, starch derivatives, etc.; and various synthetic polymers or copolymers such as polyvinyl alcohol, polyvinyl alcohol partial acetal, poly-N-vinylpyrrolidone, polyacrylic acid, polymethacrylic acid, polyacrylamide, poly- vinylimidazole, polyvinylpyrazole, etc.
  • gelatin limed gelatin as well as acid-treated gelatin may be used. Furthermore, gelatin hydrolyzed products and gelatin enzyme decomposition products can be also used.
  • a polymer latex such as a latex of alkyl acrylate.
  • films of cellulose triacetate, cellulose diacetate, nitro cellulose, polystyrene, polyethylene terephthalate, etc. can be used.
  • the film has excellent antistatic property and a support having high electric conductivity is preferably used.
  • various developing agents can be used.
  • polyhydroxybenzenes such as hydroquinone, 2-chlorohydroquinone, 2-methylhydroquinone, catechol, pyrogallol, etc.
  • aminophenols such as p-aminophenol, N-methyl-p-aminophenol, 2,4-diaminophenol, etc.
  • 3-pyrazolidones such as 1-phenyl-3-pyrazolidone, 1-phenyl-4,4-dimethyl-3-pyrazolidone, 1-phenyl-4-methyl-4-hyrdoxymethyl 3-pyrazolidone, 5,5-dimethyl-1-phenyl-3-pyrazolidone, and ascorbic acids. They can be used singly or as a combination thereof.
  • an aromatic primary amine developing agent preferably a p-phenylenediamine series developing agent
  • an aromatic primary amine developing agent preferably a p-phenylenediamine series developing agent
  • Specific examples thereof are 4--amino-3-methyl-N,N-dimethylaniline hydrochloride, N,N-diethyl-p-phenylenediamine, 3-methyl-4-amino-N-ethyl-N-g-(methanesulfonamido)ethylaniline, 3-methyl-4-amino-N-ethyl-N-( ⁇ 3-sulfoethyl)aniline, 3-ethoxy-4-amino-N ethyl-N-( ⁇ 3 - sulfoet h y l)aniline, and 4-amino-N-ethyl-N-( ⁇ 3-hydroxyethyl)aniline.
  • the developing agent described above may exist in an alkaline processing composition (processing element) or in a layer of the photographic light-sensitive element.
  • a silver halide developing agent which can cross- oxidize the DRR compound can be used in this invention.
  • the developer may contain sodium sulfite, potassium sulfite, ascorbic acid, reductants (e.g., piperidinohexose reductant), etc., as a preservative.
  • reductants e.g., piperidinohexose reductant
  • direct positive images can be obtained by developing the photographic light-sensitive element using a surface developer.
  • the development by a surface developer is induced by the latent image or fogging nucleus present at the surface of silver halide grains.
  • the developer contains no silver halide solvent but the developer may contain a silver halide solvent (e.g., a sulfite) if the internal latent images do not substantially contribute to the development until the development by the surface development center of the silver halide grains is completed.
  • a silver halide solvent e.g., a sulfite
  • the developer may further contain sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium tertiary phosphate, sodium metaborate, etc., as an alkali agent or a buffer.
  • the content of the agent is selected such that the pH of the developer became from 10.0 to 12.0, preferably not higher than 11.5, and more preferably not higher than 11.0.
  • the developer may further contain a color developer accelerator such as benzyl alcohol, etc. Furthermore, for reducing the minimum density of direct positive images formed, it is advantageous that the developer contains a compound which is usually used as an antifoggant, such as benzimidazoles (e.g., 5-nitro benzimidazole) and benzotriazoles (e.g., benzotriazole and 5-methylbenzotriazole).
  • benzimidazoles e.g., 5-nitro benzimidazole
  • benzotriazoles e.g., benzotriazole and 5-methylbenzotriazole
  • a silver halide emulsion (Emulsion A) was prepared by the following method.
  • Emulsion A Emulsion A
  • aqueous solution of potassium bromide and an aqueous solution of silver nitrate were simultaneously added to a 3% aqueous gelatin solution in the presence of 13 mg per mol of silver nitrate of 1,8-dihydroxy-3,6-dithiaoctane solvent with vigorously stirring at 75 C over a period of 5 minutes to provide an octahedral silver bromide emulsion having a mean grain size of 0.15 ⁇ m.
  • 115 mg of sodium thiosulfate and 115 mg of chloroauric acid (tetra-hydrate) per mol of silver were added to the emulsion followed by heating to 75 . C for 50 minutes to perform chemical sensitization.
  • Emulsion A thus obtained was split into 10 portions and to each portion of the emulsion were added the sensitizing dye, the nucleating agent, and the nucleation accelerator defined in this invention as shown in Table 1 below. Furthermore, 5x10- 4 mol/mol-Ag of 4-hydroxy-6-methyl-1,3,3,3a-tetraazaindene and 1x10- 3 mol/mol-Ag of 5-methylbenzotriazole were added thereto as stabilizers and also 80 mg/m 2 of 1,3- divinylsulfonyl-2-propanol was added thereto as a hardening agent.
  • an aqueous gelatin solution for a surface protective layer 30 mg/m 2 of barium strontium sulfate having a mean particle size of 1.0 ⁇ m as a matting agent, 50 mg/m 2 of hydroquinone, 20 mg/m 2 of a compound having the structure (1) shown below, and 25 mg/m 2 of sodium p-dodecylbenzenesulfonate and 5 mg/m 2 of a surface active agent having the structure (2) shown below as coating aids.
  • each of the sample was exposed to a xenon flash light of 3.75x10 5 lux through a continuous wedge for 10 -4 second. Then, each sample was developed using a Proster Plus developer (made by Eastman Kodak Company) for 30 seconds at 35°C and stopped, fixed, and washed in the conventional manner to provide positive images.
  • a Proster Plus developer made by Eastman Kodak Company
  • Dmax means the maximum density of the reversal image
  • Dmin means the minimum density thereof
  • Sp-df means an intermediate point sensitivity.
  • the intermediate point sensitivity is defined by a logE value from a standard value of giving a density of
  • sensitivity width is defined as the difference between the reversal sensitivity giving a density of Dmin+0.2 and the re-reversal negative sensitivity giving a density of Dmin+0.2 shown by the difference in LogE value and is called the "sensitivity width". As is clear from the definition, a larger sensitivity width means that the re-reversal negative is more reluctantly formed.
  • Comparison Sample No. 1 shows no reversal characteristics
  • Comparison Sample Nos. 2 to 4 show low Dmax and high Dmin
  • Comparison Sample Nos. 5 to 7 show high Dmin and small ⁇ logE 0.2 .
  • Sample Nos. 8 to 10 which are the embodiments of this invention, show very excellent photographic characteristics in terms of Dmax, Dmin, Sp-df, and ⁇ logE 0.2 as compared to the comparison samples.
  • Example 2 The same procedure as in Example 1 was followed except that the combination of the nucleating agent, the nucleation accelerator and the sensitizing dye was changed as shown in Table 3 below and further a polyethylene terephthalate film base having a subbing layer containing 300 mg/m 2 of tin oxide (Sn0 2 ) (having an electric conductivity of 10 8 ⁇ / ⁇ at relative humidity of 10%) was used as the support.
  • Sn0 2 tin oxide
  • Comparison Sample No. 1 shows no reversal characteristics
  • Comparison Sample No. 2 shows low Dmax and high Dmin
  • Comparison Sample Nos. 3 to 6 show high Dmin and small ⁇ logE 0.2 .
  • Sample Nos. 7 to 10 which are the embodiments of this invention, show very excellent photographic performance in terms of Dmax, Dmin, Sp-fd, and ⁇ logE 0.2 although Dmin in Sample No. 10 may be slightly high.
  • Example 6 The same procedure as Example 1 was followed except that the combination of the nucleating agent, the nucleation accelerator and the sensitizing dye was changed as shown in Table 5 below. The results obtained are shown in Table 6.
  • Comparison Sample No. 1 shows no reversal characteristics
  • Comparison Sample No. 2 shows low Dmax and high Dmin
  • Comparison Sample Nos. 3 to 5 show high Dmin and small ⁇ logE 0.2 .
  • Sample Nos. 6 to 11 which are the embodiments of this invention, show very excellent photographic performance in terms of Dmax, Dmin, Sp-fd, and ⁇ logE 0.2 as compared to Comparison Sample Nos. 1 to 5. In these samples, Sample Nos. 9 to 11 give particularly excellent results.
  • a silver halide emulsion (Emulsion B) was prepared as follows.
  • An aqueous solution of potassium bromide and an aqueous solution of silver nitrate were simultaneously added to a 3% aqueous gelatin solution in the presence of thioether with vigorously stirring at 75 C over a period of 5 minutes to provide an octahedral silver bromide emulsion having a mean grain size of 0.15 um.
  • the crystal growing procedure as above was further followed using the silver bromide grains thus obtained as the cores for 40 minutes under the same precipitation condition as above while controlling the pAg of the emulsion to 8.20 or 7.70 to provide an octahedral or tetradecahedral mono-dispersed core/shell silver bromide emulsion, respectively, each having a mean grain size of 0.25 ⁇ m.
  • the ratio of plane (100) in the surfaces of the entire grains contained in each emulsion was measured by the method described in Journal of Imaging Science, 29, 165(1985). Also, the another plane was plane (111).
  • Example 1 The samples as used in Examples 1 to 4 were prepared. Each of the samples was light-exposed as in Example 1, developed using each of the developers shown below for 30 seconds at 35 C, and then stopped, fixed and washed in the conventional manner. Thus, excellent positive characteristics as in Examples 1 to 4 were obtained.
  • the emulsion was split into 7 portions and the polyethylene oxide compound shown in Table 7 below was added to each portion as shown in Table 7. Furthermore, 2.5x10 -6 mol/mol-Ag of the nucleating agent (N-I-15), 8.8x10- 4 mol/mol-Ag of the nucleation accelerator (11-1), and 1.2x10 -3 mol/mol-Ag of the sensitizing dye (i-12) were added to each portion.
  • an aqueous gelatin solution for surface protective layer 30 mg/m 2 of barium strontium sulfate having a mean particle size of 1.0 ⁇ m as a matting agent, 50 mg/m 2 of hydroquinone, 20 mg/m 2 of a compound having the structural formula (1) used in Example 1, and 25 mg/m 2 of sodium p-dodecylbenzenesulfonate and 5 mg/m 2 of the surface active agent having the structural formula (2) used in Example 1 as coating aids.
  • Each of the sample was exposed to xenon flash light of 3.75x10 5 lux through a continuous wedge for 10 -4 second, developed using a Proster Plus developer, made by Eastman Kodak Company for 30 seconds at 35. C, and stopped, fixed, and washed in the conventional manner to provide positive images.
  • the polyethylene oxide compound for use in this invention increased Dmax without increasing Dmin, that is, greatly improves the discrimination.
  • Example 6 The same procedure as Example 6 was followed except that two kinds of the nucleating agents as shown in Table 9 below were used together and further a polyethylene terephthalate film base having a subbing layer containing 300 mg/m 2 of tin oxide (Sn0 2 ) (having an electric conductivity of 10 8 ⁇ / ⁇ at relative humidity of 10%) was used as the support.
  • tin oxide Sn0 2
  • the polyethylene oxide compound for use in this invention increases Dmax without increasing Dmin, that is greatly improves the discrimination even in the system of using two kinds of nucleating agents together.
  • Example 6 The samples as in Examples 6 to 8 were prepared. Each of the samples was light exposure as in Example 6, developed using each of the following developers for 30 seconds at 35 . C, and stopped, fixed, and washed in the conventional manner. In this example, excellent positive characteristics as in Examples 6 to 8 were obtained.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
EP19890103759 1988-03-04 1989-03-03 Photographisches Silberhalogenidelement für die Erzeugung direktpositiver Bilder und Verfahren zur Herstellung solcher Bilder Withdrawn EP0331185A3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5128888A JPH01224758A (ja) 1988-03-04 1988-03-04 直接ポジ画像の形成方法
JP51288/88 1988-03-04
JP15988788A JPH028836A (ja) 1988-06-28 1988-06-28 直接ポジ用ハロゲン化銀写真感光材料
JP159887/88 1988-06-28

Publications (2)

Publication Number Publication Date
EP0331185A2 true EP0331185A2 (de) 1989-09-06
EP0331185A3 EP0331185A3 (de) 1990-11-22

Family

ID=26391826

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890103759 Withdrawn EP0331185A3 (de) 1988-03-04 1989-03-03 Photographisches Silberhalogenidelement für die Erzeugung direktpositiver Bilder und Verfahren zur Herstellung solcher Bilder

Country Status (1)

Country Link
EP (1) EP0331185A3 (de)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0473209A1 (de) * 1990-07-27 1992-03-04 Agfa-Gevaert N.V. Verfahren zur Herstellung von direktpositiven Computerausgabebildern
US5283167A (en) * 1992-01-30 1994-02-01 Eastman Kodak Company Direct-positive photographic materials containing a nucleator in solid particle dispersion form
WO2000061548A1 (fr) * 1999-04-07 2000-10-19 Santen Pharmaceutical Co., Ltd. Dérivés d'urée n-substitués-n'-substitués et compositions pharmaceutiques contenant ces dérivés
US6410216B1 (en) 1992-09-11 2002-06-25 Eastman Kodak Company Method of forming a photographic color image
US8343977B2 (en) 2009-12-30 2013-01-01 Arqule, Inc. Substituted triazolo-pyrimidine compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4913570B1 (de) * 1970-10-01 1974-04-01
JPS5216223A (en) * 1975-07-29 1977-02-07 Fuji Photo Film Co Ltd Direct-positive silver halide photographic emulsion
JPH07117715B2 (ja) * 1986-06-12 1995-12-18 富士写真フイルム株式会社 直接ポジ画像の形成方法
JPH0690436B2 (ja) * 1987-12-02 1994-11-14 富士写真フイルム株式会社 直接ポジ写真感光材料

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0473209A1 (de) * 1990-07-27 1992-03-04 Agfa-Gevaert N.V. Verfahren zur Herstellung von direktpositiven Computerausgabebildern
US5283167A (en) * 1992-01-30 1994-02-01 Eastman Kodak Company Direct-positive photographic materials containing a nucleator in solid particle dispersion form
US6410216B1 (en) 1992-09-11 2002-06-25 Eastman Kodak Company Method of forming a photographic color image
WO2000061548A1 (fr) * 1999-04-07 2000-10-19 Santen Pharmaceutical Co., Ltd. Dérivés d'urée n-substitués-n'-substitués et compositions pharmaceutiques contenant ces dérivés
US6683200B2 (en) 1999-04-07 2004-01-27 Santen Pharmaceutical Co., Ltd. N-substituted-N′-substituted urea derivatives and pharmaceutical compositions containing the derivatives
US8343977B2 (en) 2009-12-30 2013-01-01 Arqule, Inc. Substituted triazolo-pyrimidine compounds

Also Published As

Publication number Publication date
EP0331185A3 (de) 1990-11-22

Similar Documents

Publication Publication Date Title
US4115122A (en) Internal latent image silver halide emulsion containing a heterocyclic quaternary salt having a propargyl or a butyryl containing substituent
EP0452848B1 (de) Photographisches Silberhalogenidmaterial
US5075198A (en) Silver halide photographic material
US4956257A (en) Silver halide photographic material and method for forming an image
US4552828A (en) Direct positive silver halide photographic emulsion
US4639416A (en) Internal latent image-type silver halide emulsion
US4725532A (en) Silver halide photographic light-sensitive material and high contrast negative image forming process using them
EP0140371B1 (de) Vom internen Latentbildtyp direktes positives lichtempfindliches Silberhalogenidmaterial
US5093222A (en) Silver halide photographic materials
US5387483A (en) Processing of lithographic printing material and developer used therein
US5145765A (en) Silver halide photographic material
EP0331185A2 (de) Photographisches Silberhalogenidelement für die Erzeugung direktpositiver Bilder und Verfahren zur Herstellung solcher Bilder
JP2889960B2 (ja) ハロゲン化銀写真感光材料
JP2670842B2 (ja) 直接ポジ用ハロゲン化銀写真感光材料
US5015561A (en) Method for forming a direct positive image
US4094683A (en) Direct positive silver halide photographic materials
US5035984A (en) Method for forming a direct positive image
EP0598241B1 (de) Lithographisches Druckmaterial
US4634653A (en) Direct positive silver halide photographic emulsion
JP2583439B2 (ja) 直接ポジ画像の形成方法
JP2654703B2 (ja) 直接ポジ画像の形成方法
JPH01224758A (ja) 直接ポジ画像の形成方法
JPH01224757A (ja) 直接ポジ画像の形成方法
JPH0325435A (ja) 医療用画像形成方法
JPH06208227A (ja) 平版印刷材料

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE GB

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): DE GB

17P Request for examination filed

Effective date: 19910214

17Q First examination report despatched

Effective date: 19940304

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19940915